Palo Alto, CA, United States of America

Wei-Qiang Gao

This inventor holds 45 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Polypeptide Therapeutics. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 2000-2010.

USPTO Granted Patents = 45 

% Patents Active = 91.1

 

Average Co-Inventor Count = 3.8

ph-index = 12

Forward Citations = 569(Granted Patents)


Location History:

  • Foster City, CA (US) (2000 - 2006)
  • Palo Alto, CA (US) (2003 - 2010)

Company Filing History:


Years Active: 2000-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
PRO350 Antibodies
PRO1475 Polypeptide
Anti-PRO6181 Antibodies
Secreted Polypeptides
Transmembrane Polypeptides
Nucleic Acids
PRO6097 Polypeptides
Anti-PRO1347 Antibodies
Notch Receptor Agonists
Treatment of Balance Impairments
Inner Ear Hair Cells
Tumor Diagnosis
45 patents (USPTO):Explore Patents

Title: The Innovative Journey of Wei-Qiang Gao

Introduction: Wei-Qiang Gao is a visionary inventor based in Palo Alto, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Wei-Qiang Gao holds several patents in the areas of artificial intelligence, machine learning, and renewable energy technologies, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Wei-Qiang Gao has worked with leading tech companies, research institutions, and universities, where he has spearheaded projects that have revolutionized the industry.

Collaborations: Wei-Qiang Gao has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge sharing that has led to significant advancements in various technological domains.

Conclusion: Wei-Qiang Gao's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a pioneering inventor in the tech industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…